Menu

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

Article |

Crypto699Viking 7mo ago
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a clinical-stage biopharmaceutical company developing...

Comments (0)

Newest

No comments yet.